Software as a service provider (saas) that obtains general pharmaceutical data and retrospective pricing and synthesizes clinical pipeline data and medical/pharmacy benefit crosswalks specific to medicaid into a single platform. This platform must be able to provide forward-looking, loss-of-exclusivity projections required for proactive medicaid fiscal forecasting and single preferred drug list management and blends patent law with pharmacy clinical/financial forecasting. Provide comprehensive pharmacy and therapeutic management strategy, supporting formulary, clinical, contracting, and market-access decisions. Also provide in-depth analysis regarding drug availability, clinical data, clinical pipeline tracking, evidence-based clinical pathways, preferred products, and site of care, disease class-specific strategy reports, drug alerts, pipeline trend reports, and new-drug reviews, assessments of potential new brand product prevalence and pricing impacts prior to launch.